Featured image about Ebola vaccine development showing an Ebola vaccine vial, virus illustration, syringe, laboratory setting, and key data including 100% estimated efficacy in the Guinea ring-vaccination trial, 98% real-world effectiveness in DRC outbreak analysis, 518,890 stockpiled doses, and ongoing challenges such as species gaps, durability, and vaccine deployment.
Uncategorized

Why there is still no Universal Ebola Vaccine

/

Ebola vaccine development has made major progress, moving from experimental research to licensed vaccines and real-world outbreak control. Yet important challenges remain, including limited protection across all Ebola species, uncertain durability of immunity, and the difficulty of testing vaccines during unpredictable outbreaks.